Cannabidiol (CBD) is the non psychoactive phytocannabinoid metabolite present in marijuana. It possesses antioxidant and anti-inflammatory properties exploited in drug discovery for neurodegenerative disorders. CBD has effectively treated degenerative disease symptoms, making it a preferred treatment method amongst the current generation. Not only does it lack a psychoactive nature, but research also suggests that it counteracts heightened anxiety and paranoia caused by THC.
CBD has gained popularity because it is nonpsychotic and treats without mind-altering effects associated with its counterpart metabolite THC. Its popularity is due to the following factors. This article highlights in-depth information on how CBD is the right candidate for drug development. Degenerative diseases that can be treated using CBD concentrates include and are not limited to the following.
What Are Degenerative Disorders?
This condition results in the loss of function of the central nervous system and muscle coordination leading to cell death. Chemicals, viruses, and genetic complications attack the central nervous system to cause neurodegenerative diseases. There are various degenerative disorders, but the following are those that can be treated using CBD concentrates.
1. Alzheimer’s Disease
This degenerative disease causes wastage and death of brain cells resulting in severe memory impairment and inability to perform daily tasks. A low level of antioxidant enzymes in the central nervous system and many reactive oxygen species causes oxidative stress. Free radicals attack neural cells resulting in sensory loss and memory loss.
CBD contains high amounts of antioxidants blocking the buildup of neural plaque by preventing the interaction of oxidative stress and free radicals. Its wide variety of applications treats anxiety, insomnia, and inflammation, which are acute symptoms of Alzheimer’s disease.
2. Multiple Sclerosis
Pharmaceutical nasal sprays containing CBD concentrates have been shown to improve muscle tightness, manage pain, and increase urination frequency. This has helped people with multiple sclerosis manage their symptoms.
3. Parkinson’s Disease
Research shows that taking single doses of CBD reduces anxiety experienced by individuals with Parkinson’s disease. The action mechanism is similar to that discussed on Alzheimer’s disease, where CBD antioxidant properties prevent interaction of oxidative stress with free metals.
Parkinson’s disease can additionally cause pain during disease progression. Activation of the endocannabinoid system by use of CBD relieves pain, helping manage its symptoms.
This neurological disorder causes abnormal brain activity that results in seizures, sensations, and loss of awareness. Cannabidiol products have shown considerable effects at reducing seizures in children and individuals with febrile infection-related epilepsy syndrome.
Neuroprotective abilities of CBD have been shown to treat delusional thinking in patients with schizophrenia by managing anxiety and depression.
Having discussed degenerative diseases treatable with CBD, characteristics that make CBD suitable include:
• Relieves pain
• Has anti-tumor properties
• Rich in antioxidants
• Lacks psychoactivity
• Has neuroprotective properties
CBD interacts with the network of cannabinoid receptors, providing promising treatment strategies with high precision in targeting substrates causing neurodegeneration. This is a promising drug discovery technique. Other conditions treated using CBD include:
• Injury rehabilitation
• High blood pressure
• Chronic pain
These statements have not been evaluated by the food and drug administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.